"The pharmaceutical industry is not going to turn their back on potentially massively increased profits because they don't like PAR management. They will find a way to work with them."
How much more evidence do you need that this isn't the case?
Any asset that has the potential of iPPS would have been snapped up/partnered a long time ago.
PAR Price at posting:
28.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)